CRNX - Crinetics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
2018-12-30
2017-12-30
2016-12-30
Assets
Current Assets
Cash
Cash And Cash Equivalents
44,973
14,192
12,152
Short Term Investments
118,902
-
-
Total Cash
163,875
14,192
12,152
Net Receivables
-
-
-
Inventory
-
-
-
Other Current Assets
-
98
43
Total Current Assets
166,683
15,165
12,365
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,973
704
406
Accumulated Depreciation
-741
-304
-182
Net property, plant and equipment
4,232
400
224
Equity and other investments
-
-
-
Goodwill
-
-
-
Intangible Assets
-
-
-
Other long-term assets
500
33
10
Total non-current assets
4,732
433
234
Total Assets
171,415
15,598
12,599
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
-
49
Accounts Payable
1,456
403
340
Taxes payable
-
-
-
Accrued liabilities
3,809
179
229
Deferred revenues
-
-
-
Other Current Liabilities
-
-
-
Total Current Liabilities
7,925
897
890
Non-current liabilities
Long Term Debt
-
-
163
Deferred taxes liabilities
-
-
-
Deferred revenues
-
-
-
Other long-term liabilities
202
3
5
Total non-current liabilities
3,265
29,723
17,913
Total Liabilities
11,190
30,620
18,803
Stockholders' Equity
Common Stock
24
1
1
Retained Earnings
-43,380
-16,265
-7,108
Accumulated other comprehensive income
61
-
-
Total stockholders' equity
160,225
-15,022
-6,204
Total liabilities and stockholders' equity
171,415
15,598
12,599